Abnormal cerebrospinal fluid (CSF) levels of β-amyloid peptides (Aβ42) and Tau and cognitive decline are typical characteristics of Alzheimer’s disease (AD). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.